Pharmacological inhibition of leukotriene actions (Q27863451)

Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma

volume

20

0 references

issue

2

0 references

page(s)

60-5

0 references

cites work

1 reference

12 December 2020

Biology and pathophysiology of leukotrienes

1 reference

12 December 2020

Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses

1 reference

12 December 2020

Inhibition of allergic and non-allergic inflammation by phospholipase A2 inhibitors

1 reference

12 December 2020

The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma

1 reference

12 December 2020

Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity.

1 reference

12 December 2020

The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics.

1 reference

12 December 2020

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

1 reference

12 December 2020

The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma

1 reference

12 December 2020

Effect of SC-41930, a potent selective leukotriene B4 receptor antagonist, in the guinea pig model of middle ear inflammation

1 reference

12 December 2020

Leukotrienes C4, D4, and E4 enhance histamine responsiveness in asthmatic airways.

1 reference

12 December 2020

Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor

1 reference

12 December 2020

Leukotriene C: a slow-reacting substance from murine mastocytoma cells

1 reference

12 December 2020

The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis

1 reference

12 December 2020

Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.

1 reference

12 December 2020

A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids

1 reference

12 December 2020

The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo

1 reference

12 December 2020

The mechanism of vascular leakage induced by leukotriene E4. Endothelial contraction

1 reference

12 December 2020

Molecular pharmacology of manoalide. Inactivation of bee venom phospholipase A2.

1 reference

12 December 2020

Overview of allergic mechanisms. Ebastine has more than an antihistamine effect

1 reference

12 December 2020

The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air

1 reference

12 December 2020

Selective chiral inhibitors of 5-lipoxygenase with anti-inflammatory activity

1 reference

12 December 2020

Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses

1 reference

12 December 2020

Thielocins A1.ALPHA. and A1.BETA., novel phospholipase A2 inhibitors from ascomycetes

1 reference

12 December 2020

The effect of cetirizine on sulfidoleukotriene production by blood leukocytes in children with allergic rhinitis

1 reference

12 December 2020

5-Lipoxygenase activating protein and leukotriene C4 synthase: therapeutic targets for inhibiting the leukotriene cascade

1 reference

12 December 2020

The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma

1 reference

12 December 2020

Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion

1 reference

12 December 2020

Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature.

1 reference

12 December 2020

Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase Inhibitor

1 reference

12 December 2020

In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma

1 reference

12 December 2020

Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro

1 reference

12 December 2020

Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis

1 reference

12 December 2020

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

1 reference

12 December 2020

Novel structural and functional properties of leukotriene A4 hydrolase. Implications for the development of enzyme inhibitors.

1 reference

12 December 2020

Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response

1 reference

12 December 2020

Leukotriene E4 and granulocytic infiltration into asthmatic airways

1 reference

12 December 2020

Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects

1 reference

12 December 2020

The effect of an inhaled leukotriene antagonist, L-648,051, on early and late asthmatic reactions and subsequent increase in airway responsiveness in man

1 reference

12 December 2020

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

1 reference

12 December 2020

Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist

1 reference

12 December 2020

Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils

1 reference

12 December 2020

Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group

1 reference

12 December 2020

(E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonists

1 reference

12 December 2020

Inhibition of leukotriene synthesis by azelastine

1 reference

12 December 2020

Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma

1 reference

12 December 2020

Leukotriene B4 production by blood neutrophils in allergic rhinitis--effects of cetirizine

1 reference

12 December 2020

Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients

1 reference

12 December 2020

Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group

1 reference

12 December 2020

Liberation of histamine and formation of lysocithin-like substances by cobra venom

1 reference

12 December 2020

LY255283, a novel leukotriene B4 receptor antagonist, limits activation of neutrophils and prevents acute lung injury induced by endotoxin in pigs

1 reference

12 December 2020

Effect of cetirizine on antigen-induced tracheal contraction of passively sensitized guinea pigs

1 reference

12 December 2020

1 reference

12 December 2020

MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.

1 reference

12 December 2020

Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors

1 reference

12 December 2020

Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo

1 reference

12 December 2020

Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products

1 reference

12 December 2020

Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma

1 reference

12 December 2020

Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.

1 reference

12 December 2020